Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.22.4
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]        
Revenue $ 5,865 $ 3,672 $ 11,432 $ 5,540
Cost of revenue 5,274 4,549 11,727 7,451
Gross profit (loss) 591 (877) (295) (1,911)
Operating expenses        
Research and development 7,645 9,192 17,730 17,166
General and administrative expenses 5,838 5,146 12,833 9,022
Total operating expenses 13,483 14,338 30,563 26,188
Loss from operations (12,892) (15,215) (30,858) (28,099)
Other (expense) income        
Interest (expense) income (702) 28 (1,445) 62
Other (expense) income 5 (9)
Change in fair value of contingent consideration 1,616 1,170
Change in fair value of derivative liabilities 818 839
Total other (expense) income 1,737 28 555 62
Net loss before income taxes (11,155) (15,187) (30,303) (28,037)
Income Tax (expense) benefit (1) (58) 56 (58)
Net Loss (11,156) (15,245) (30,247) (28,095)
Net loss (income) attributable to noncontrolling interest (19) (19)
Net loss attributable to common stockholders $ (11,156) $ (15,264) $ (30,247) $ (28,114)
Net loss per common share - basic and diluted (in Dollars per share) $ (0.19) $ (0.29) $ (0.53) $ (0.54)
Weighted average common shares outstanding - basic and diluted (in Shares) 57,583,844 52,924,078 57,369,118 52,180,077